395 related articles for article (PubMed ID: 31389270)
1. Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction.
Kozáková J; Altay A; Ždímal V; Mašková L; Sonvico F; Quarta E; Rossi A; Buttini F; Colombo G
Drug Dev Ind Pharm; 2019 Oct; 45(10):1664-1673. PubMed ID: 31389270
[TBL] [Abstract][Full Text] [Related]
2. Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections.
Mangal S; Huang J; Shetty N; Park H; Lin YW; Yu HH; Zemlyanov D; Velkov T; Li J; Zhou QT
Int J Pharm; 2019 Apr; 561():102-113. PubMed ID: 30797863
[TBL] [Abstract][Full Text] [Related]
3. Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.
Zhou QT; Morton DA; Yu HH; Jacob J; Wang J; Li J; Chan HK
J Pharm Sci; 2013 Oct; 102(10):3736-47. PubMed ID: 23904207
[TBL] [Abstract][Full Text] [Related]
4. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Impacts of Surface Compositions on the In-Vitro Dissolution and Aerosolization of Co-Spray-Dried Composite Powder Formulations for Inhalation.
Mangal S; Xu R; Park H; Zemlyanov D; Shetty N; Lin YW; Morton D; Chan HK; Li J; Zhou QT
Pharm Res; 2018 Nov; 36(1):6. PubMed ID: 30406281
[TBL] [Abstract][Full Text] [Related]
6. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
Meenach SA; Vogt FG; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776
[TBL] [Abstract][Full Text] [Related]
7. Spray dried amikacin powder for inhalation in cystic fibrosis patients: a quality by design approach for product construction.
Belotti S; Rossi A; Colombo P; Bettini R; Rekkas D; Politis S; Colombo G; Balducci AG; Buttini F
Int J Pharm; 2014 Aug; 471(1-2):507-15. PubMed ID: 24886692
[TBL] [Abstract][Full Text] [Related]
8. Redispersible liposomal-N-acetylcysteine powder for pulmonary administration: development, in vitro characterization and antioxidant activity.
Ourique AF; Chaves Pdos S; Souto GD; Pohlmann AR; Guterres SS; Beck RC
Eur J Pharm Sci; 2014 Dec; 65():174-82. PubMed ID: 25263567
[TBL] [Abstract][Full Text] [Related]
9. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
[TBL] [Abstract][Full Text] [Related]
10. Dextran Microparticulate Inhalable Dry Powder for the Treatment of Cystic Fibrosis and Mucopolysaccharidosis.
Solanki NR; Patel DH; Talele DR
Curr Drug Deliv; 2020; 17(3):218-228. PubMed ID: 31969100
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
Li X; Vogt FG; Hayes D; Mansour HM
Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
[TBL] [Abstract][Full Text] [Related]
12. Inhalable Nanocomposite Microparticles with Enhanced Dissolution and Superior Aerosol Performance.
Zhu C; Chen J; Yu S; Que C; Taylor LS; Tan W; Wu C; Zhou QT
Mol Pharm; 2020 Sep; 17(9):3270-3280. PubMed ID: 32643939
[TBL] [Abstract][Full Text] [Related]
13. Design of spray dried insulin microparticles to bypass deposition in the extrathoracic region and maximize total lung dose.
Ung KT; Rao N; Weers JG; Huang D; Chan HK
Int J Pharm; 2016 Sep; 511(2):1070-9. PubMed ID: 27480399
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.
Jong T; Li J; Morton DA; Zhou QT; Larson I
J Pharm Sci; 2016 Mar; 105(3):1156-63. PubMed ID: 26886330
[TBL] [Abstract][Full Text] [Related]
15. Particle engineering of materials for oral inhalation by dry powder inhalers. II-Sodium cromoglicate.
Nolan LM; Li J; Tajber L; Corrigan OI; Healy AM
Int J Pharm; 2011 Feb; 405(1-2):36-46. PubMed ID: 21129460
[TBL] [Abstract][Full Text] [Related]
16. Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers.
Acosta MF; Abrahamson MD; Encinas-Basurto D; Fineman JR; Black SM; Mansour HM
AAPS J; 2020 Nov; 23(1):2. PubMed ID: 33200330
[TBL] [Abstract][Full Text] [Related]
17. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
[TBL] [Abstract][Full Text] [Related]
19. Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.
Akdag Cayli Y; Sahin S; Buttini F; Balducci AG; Montanari S; Vural I; Oner L
Drug Dev Ind Pharm; 2017 Aug; 43(8):1378-1389. PubMed ID: 28420285
[TBL] [Abstract][Full Text] [Related]
20. Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections.
Matinkhoo S; Lynch KH; Dennis JJ; Finlay WH; Vehring R
J Pharm Sci; 2011 Dec; 100(12):5197-205. PubMed ID: 22020816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
